Saar Gill, MD: Combining CAR T-Cell Therapy With Ibrutinib in CLL Patients
1 Visualizações
• 07/14/23
0
0
Embutir
administrator
Assinantes
Adding ibrutinib to treatment with CAR T-cell therapy was feasible, led to deeper remissions, and reduced the severity of cytokine release syndrome in patients with chronic lymphocytic leukemia.
Mostre mais
Comentários do Facebook
SORT BY-
Melhores Comentários
-
Últimos Comentários